humanized glp-1 receptor knock-in mouse Chronic treatment with glucagon-like peptide-1 and glucagon co- agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity Generation and characterisation of a

Clostridium butyricum produces the postbiotic butyrate which stimulates GLP-1. Bifidobacterium infantis produces the postbiotics acetate and lactate which feed bacteria such as Akkermansia and Butyricum, promoting an ecosystem in the gut that supports a healthy gut lining and naturally boosts GLP-1

Dong Y, Carty J, Goldstein N, He Z, Hwang E, Chau D, et al

This ongoing medical supervision is a key component of our GLP-1 weight loss program

Where public coverage is limited and self-pay remains the main route, adoption follows a clear S-curve tied to the affordability ratio (AR) the share of a consumers disposable income required for one month of therapy